Search Results

NaV1.6 dysregulation within myocardial T-tubules by D96V calmodulin enhances proarrhythmic sodium and calcium mishandling.

• Authors : Tarasov M; The Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Division of Outcomes and Translational Sciences, College of Pharmacy.

Subjects: Calmodulin*/Calmodulin*/Calmodulin*/genetics ; Calmodulin*/Calmodulin*/Calmodulin*/metabolism ; Long QT Syndrome*/Long QT Syndrome*/Long QT Syndrome*/genetics

• Source: The Journal of clinical investigation [J Clin Invest] 2023 Apr 03; Vol. 133 (7). Date of Electronic Publication: 2023 Apr 03.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding-deficient channels.

• Authors : Abrams J; Division of Cardiology, Department of Medicine.; Roybal D

Subjects: Action Potentials* ; Mutation*; Arrhythmias, Cardiac/Arrhythmias, Cardiac/Arrhythmias, Cardiac/*pathology

• Source: JCI insight [JCI Insight] 2020 Oct 02; Vol. 5 (19). Date of Electronic Publication: 2020 Oct 02.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia.

• Authors : Nakamura Y; Department of Medicine and Clinical Science, Division of Cardiology, and.; Yamamoto T

Subjects: Calmodulin*/Calmodulin*/Calmodulin*/chemistry ; Calmodulin*/Calmodulin*/Calmodulin*/metabolism ; Ryanodine Receptor Calcium Release Channel*/Ryanodine Receptor Calcium Release Channel*/Ryanodine Receptor Calcium Release Channel*/chemistry Polymorphic catecholergic ventricular tachycardia

• Source: JCI insight [JCI Insight] 2019 Jun 06; Vol. 4 (11). Date of Electronic Publication: 2019 Jun 06 (Print Publication: 2019).Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model:

Record details

1.6 dysregulation within myocardial T-tubules by D96V calmodulin enhances proarrhythmic sodium and calcium mishandling

• Authors : Tarasov, Mikhail; Struckman, Heather L.; Olgar, Yusuf

• Source: Journal of Clinical Investigation. April 1, 2023, Vol. 133 Issue 7

Record details

Retinoic acid inhibits calmodulin binding to human erythrocyte membranes and reduces membrane Ca2(+)-adenosine triphosphatase activity.

• Authors : Davis FB; Department of Medicine, State University of New York, Buffalo School of Medicine and Biomedical Sciences.; Smith TJ

Subjects: Calcium-Transporting ATPases/Calcium-Transporting ATPases/Calcium-Transporting ATPases/*antagonists & inhibitors ; Calmodulin/Calmodulin/Calmodulin/*metabolism ; Erythrocyte Membrane/Erythrocyte Membrane/Erythrocyte Membrane/*metabolism

• Source: The Journal of clinical investigation [J Clin Invest] 1990 Jun; Vol. 85 (6), pp. 1999-2003.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel.

• Authors : Yamaguchi N; Department of Biochemistry and Biophysics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Takahashi N

Subjects: Mutagenesis, Site-Directed*; Calmodulin/Calmodulin/Calmodulin/*physiology ; Cardiomegaly/Cardiomegaly/Cardiomegaly/*genetics

• Source: The Journal of clinical investigation [J Clin Invest] 2007 May; Vol. 117 (5), pp. 1344-53. Date of Electronic Publication: 2007 Apr 12.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Altered binding of 125I-labeled calmodulin to a 46.5-kilodalton protein in skin fibroblasts cultured from patients with cystic fibrosis.

• Authors : Tallant EA; Wallace RW

Subjects: Calmodulin/Calmodulin/Calmodulin/*metabolism ; Calmodulin-Binding Proteins/Calmodulin-Binding Proteins/Calmodulin-Binding Proteins/*metabolism ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*metabolism

• Source: The Journal of clinical investigation [J Clin Invest] 1987 Feb; Vol. 79 (2), pp. 643-8.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.

• Authors : Agre P; Virshup D; Bennett V

Subjects: Azepines/Azepines/Azepines/*pharmacology ; Calcium/Calcium/Calcium/*pharmacology ; Calcium Channel Blockers/Calcium Channel Blockers/Calcium Channel Blockers/*pharmacology

• Source: The Journal of clinical investigation [J Clin Invest] 1984 Sep; Vol. 74 (3), pp. 812-20.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Role of calmodulin in platelet aggregation. Structure-activity relationship of calmodulin antagonists.

• Authors : Nishikawa M; Hidaka H

Subjects: Calcium-Binding Proteins/Calcium-Binding Proteins/Calcium-Binding Proteins/*antagonists & inhibitors ; Calmodulin/Calmodulin/Calmodulin/*antagonists & inhibitors ; Platelet Aggregation/Platelet Aggregation/Platelet Aggregation/*drug effects

• Source: The Journal of clinical investigation [J Clin Invest] 1982 Jun; Vol. 69 (6), pp. 1348-55.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Calcium/calmodulin-mediated action of calcitonin on lipid metabolism in rats.

• Authors : Nishizawa Y; Second Department of Internal Medicine, Osaka City University Medical School, Japan.; Okui Y

Subjects: Lipid Metabolism*; Calcitonin/Calcitonin/Calcitonin/*administration & dosage ; Calcium/Calcium/Calcium/*physiology

• Source: The Journal of clinical investigation [J Clin Invest] 1988 Oct; Vol. 82 (4), pp. 1165-72.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details